| Dr Jonathan A Israel, MD | |
|
6585 S Yale Ave Ste 720, Tulsa, OK 74136-8320 | |
| (918) 502-5930 | |
| (918) 502-5935 |
| Full Name | Dr Jonathan A Israel |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 12 Years |
| Location | 6585 S Yale Ave Ste 720, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407122427 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 34657 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Francis Hospital, Inc | Tulsa, OK | Hospital |
| Saint Francis Hospital South, Llc | Tulsa, OK | Hospital |
| Saint Francis Hospital Vinita, Inc | Vinita, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Warren Clinic Inc | 8820900293 | 604 |
| Ahs Oklahoma Physician Group Llc | 9436122496 | 298 |
News Archive
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Environmental health scientist Alicia Timme-Laragy at the University of Massachusetts Amherst recently received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the health effects of two environmental pollutants, perfluoro-octanesulfonic acid (PFOS) and its recent replacement chemical, perfluoro-butanesulfonic (PFBS).
Early this year, the COVID-19 outbreak began in the United States in a muted manner, simmering over a few weeks to emerge as a full-fledged epidemic in New York and other states. Now, a new study published on the preprint server medRxiv* in June 2020 reveals the pattern of community spread throughout the sheltering-in-place period in San Francisco.
› Verified 9 days ago
| Entity Name | Warren Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174582282 PECOS PAC ID: 8820900293 Enrollment ID: O20031104000252 |
News Archive
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Environmental health scientist Alicia Timme-Laragy at the University of Massachusetts Amherst recently received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the health effects of two environmental pollutants, perfluoro-octanesulfonic acid (PFOS) and its recent replacement chemical, perfluoro-butanesulfonic (PFBS).
Early this year, the COVID-19 outbreak began in the United States in a muted manner, simmering over a few weeks to emerge as a full-fledged epidemic in New York and other states. Now, a new study published on the preprint server medRxiv* in June 2020 reveals the pattern of community spread throughout the sheltering-in-place period in San Francisco.
› Verified 9 days ago
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Environmental health scientist Alicia Timme-Laragy at the University of Massachusetts Amherst recently received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the health effects of two environmental pollutants, perfluoro-octanesulfonic acid (PFOS) and its recent replacement chemical, perfluoro-butanesulfonic (PFBS).
Early this year, the COVID-19 outbreak began in the United States in a muted manner, simmering over a few weeks to emerge as a full-fledged epidemic in New York and other states. Now, a new study published on the preprint server medRxiv* in June 2020 reveals the pattern of community spread throughout the sheltering-in-place period in San Francisco.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jonathan A Israel, MD 6600 S Yale Ave Ste 1400, Tulsa, OK 74136-3331 Ph: (888) 247-0125 | Dr Jonathan A Israel, MD 6585 S Yale Ave Ste 720, Tulsa, OK 74136-8320 Ph: (918) 502-5930 |
News Archive
Senesco Technologies, Inc. reported today the completion of cohort 3 of its Phase 1b/2a clinical trial for its drug, SNS01-T, for the treatment of multiple myeloma and lymphoma. The Company has also received approval from its Data Review Committee to proceed to cohort 4, which is expected to require six evaluable patients.
In multiple sclerosis, the immune system goes rogue, improperly attacking the body's own central nervous system. Mobility problems and cognitive impairments may arise as the nerve cells become damaged.
Environmental health scientist Alicia Timme-Laragy at the University of Massachusetts Amherst recently received a $1.9 million grant from the National Institute of Environmental Health Sciences to study the health effects of two environmental pollutants, perfluoro-octanesulfonic acid (PFOS) and its recent replacement chemical, perfluoro-butanesulfonic (PFBS).
Early this year, the COVID-19 outbreak began in the United States in a muted manner, simmering over a few weeks to emerge as a full-fledged epidemic in New York and other states. Now, a new study published on the preprint server medRxiv* in June 2020 reveals the pattern of community spread throughout the sheltering-in-place period in San Francisco.
› Verified 9 days ago
Dr. Dae Y Kim, M.D., PH.D Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 | |
Dr. Clarence Michael Johnson, D.O. Urology Medicare: Not Enrolled in Medicare Practice Location: 802 S Jackson Ave, Suite 110, Tulsa, OK 74127 Phone: 918-599-4477 Fax: 918-599-4479 | |
Bruce Carlton Stoesser, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 10901 E 48th St S, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Kevin Joseph Gancarczyk, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Rustin Chanc Walters, M.D. Urology Medicare: Medicare Enrolled Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Jack Steve Miller, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 10901 E 48th St, Tulsa, OK 74146 Phone: 918-749-8765 Fax: 918-392-2155 | |
Dr. Paul G Hagood, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Ste 202, Tulsa, OK 74104 Phone: 918-579-3130 Fax: 918-579-3139 |